Michael Grusch

28PUBLICATIONS
69CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Molecular targetsLiquid biopsiesPredictive and prognostic markersInfectious agents
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|May 04, 2026
MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma.

|Feb 27, 2026
Optogenetics for Investigating and Targeting Hallmark Traits of Cancer.

Hannah Kienbacher, Muhammad Hashim, Michael Grusch

|Feb 17, 2026
The micronucleus assay in exfoliated buccal cells induced by lifestyle factors: an overview.

Siegfried Knasmüller, Armen Nersesyan, Miroslav Mišík

|Jan 28, 2026
Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural Mesothelioma.

Muhammad Hashim, Gerald Timelthaler, Dominik Kirchhofer

|Dec 14, 2025
Fibroblast growth factor signals drive the metastatic behavior in small cell lung cancer.

Büsra Ernhofer, Anna Solta, Julia Sinner

|Sep 04, 2025
Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesothelioma.

Karin Schelch, Nadine Maach, Muhammad Hashim

Pageof 5

Frequent Collaborators

10 joint publications

Walter Berger

9 joint publications

Balazs Dome

6 joint publications

Clemens Aigner

6 joint publications

Balazs Hegedus